site stats

Phesgo patient information leaflet

WebPatient leaflet - Phesgo Package leaflet: Information for the user Phesgo 600 mg/600 mg solution for injection Phesgo 1200 mg/600 mg solution for injection … WebPhesgo® contains two separate monoclonal antibodies, trastuzumab and pertuzumab. Previously, trastuzumab and pertuzumab were used separately or in combination to …

Printable Resources PHESGO® (pertuzumab / …

WebIndications Early Breast Cancer. PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is indicated for use in combination with chemotherapy for. the neoadjuvant … sims 4 free download full game on fire kindle https://principlemed.net

Phesgo - patient leaflet, side effects, dosage Patient info

WebPatient Information Leaflet: Phesgo contains sucrose which may have an effect on the control of your blood sugar if you have diabetes mellitus. If you have been told by your … WebPhesgo (‘f-ehz-go’) is a treatment which has been created to treat HER2-positive breast cancer. Phesgo is made up of two drugs, called pertuzumab (‘pert-ooz-oo-mab’) and … WebPhesgo ® combines pertuzumab with trastuzumab. Your nurse gives it to you as an injection under the skin over several minutes. They monitor you for a while afterwards. Your doctor … sims 4 free download full game all dlc

INFORMATION FOR PATIENTS YOUR GUIDE

Category:Phesgo 600 mg/600 mg solution for injection - medicines

Tags:Phesgo patient information leaflet

Phesgo patient information leaflet

Side Effects & Tips You Can Try PHESGO® (pertuzumab / …

WebRoche Resources WebJan 13, 2024 · A Patient Information Leaflet (PIL) is the leaflet for patients containing information on taking a medicine, that is included with the medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean that …

Phesgo patient information leaflet

Did you know?

WebPHESGO TM is indicated for use in combination with docetaxel for the treatment of adult patients with HER2-positive metastatic breast cancer (MBC) who have not received prior … WebOct 13, 2024 · If Phesgo is administered during pregnancy, or if a patient becomes pregnant while receiving Phesgo or within 7 months following the last dose of Phesgo, health care providers and patients should immediately report Phesgo exposure to Genentech at 1-888-835-2555. It is unknown if Phesgo passes into breast milk or how it could affect a nursing ...

WebAug 8, 2024 · Phesgo is a cancer medicine that is used alone or with other medicines to treat early-stage breast cancer. Phesgo is also used to treat HER2-positive breast cancer that is advanced or has spread to other parts of the body (metastatic). Phesgo is used for breast cancer only if your tumor tests positive for a protein called human epidermal … WebMar 18, 2024 · Phesgo 600 mg/600 mg solution for injection Active Ingredient: trastuzumab, pertuzumab Company: Roche Products Limited See contact details ATC code: L01XY02 …

WebPhesgo 1200 mg/600 mg/30,000 units (providing 1200 mg pertuzumab, 600 mg trastuzumab and 30,000 units hyaluronidase per 15 mL) single-dose vials: 50242-0245-xx Phesgo 600 mg/600 mg/20,000 units (providing 600 mg pertuzumab, 600 mg trastuzumab and 20,000 units hyaluronidase per 10 mL) single-dose vials: 50242-0260-xx VII. … WebJun 29, 2024 · Data showed that 85% of patients preferred Phesgo compared to standard intravenous administration South San Francisco, CA -- June 29, 2024 -- ... Phesgo Indications and Important Safety Information. Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: ...

WebNov 1, 2024 · Phesgo is indicated for use in combination with docetaxel for the treatment of adult patients with HER2-positive metastatic breast cancer who have not received prior …

WebMar 1, 2024 · of PHESGO (600 mg pertuzumab and 600 mg trastuzumab) on your next visit may be given over 5 minutes. This maintenance dose will follow every 3 weeks. You will … sims 4 free download hp laptopWebJan 13, 2024 · A Patient Information Leaflet (PIL) is the leaflet for patients containing information on taking a medicine, that is included with the medicine packaging. It is … rbs radiationWebPHESGO treatment in patients receiving adjuvant therapy and withhold PHESGO in patients with metastatic disease for clinically significant decrease in left ventricular function [see … rbsp trading limitedWebPHESGO ™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant … sims 4 free download on octoberWebDiscontinue Phesgo in patients receiving adjuvant therapy and withhold in patients with metastatic disease for clinically significant decrease in LVEF; Embryofetal toxicity. Exposure to Phesgo can result in embryofetal death and birth defects, including oligohydramnios and oligohydramnios sequence manifesting as pulmonary hypoplasia, skeletal ... sims 4 free download october 18thWebPHESGO can cause left ventricular cardiac dysfunction, arrhythmias, hypertension, disabling cardiac failure, cardiomyopathy, and cardiac death PHESGO can also cause … rbs purchasing cardWebMar 25, 2024 · This Phase III, randomized, two-arm, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus Phesgo compared with Phesgo after induction therapy with Phesgo plus taxane in participants with human epidermal growth factor receptor 2 (HER2)-positive, estrogen receptor (ER)-positive advanced breast cancer … sims 4 free download kindle